Support of educational events. Participation of World Medicine in the First Congress of Optometrists of Ukraine.

On February 15, 2025, the First Congress of Optometrists of Ukraine was held. The event was held in two formats, offline and online, on the territory of the State Enterprise “National Kyiv.

The event was attended by more than 200 medical professionals practicing optometry, students of professional cycles of thematic improvement and specialization, interns, and graduate students. There were 35 speakers and trainers from Ukraine, Latvia, Great Britain and Germany.

Scientific organizers:

  • Department of Ophthalmology and Optometry of the Bogomolets National Medical University
  • NGO “Association of Pediatric Ophthalmologists and Optometrists of Ukraine”
  • NGO “Society of Optometrists of Ukraine”

The pharmaceutical company World Medicine has traditionally supported this significant event. We have a large portfolio of medicines that are used daily in the practice of ophthalmologists, ophthalmic surgeons and other specialists, which was recognized by a diploma for participation in the congress.

The place of our medicines, namely CIRELAX, was highlighted in the master class of the Chief Medical Officer of Luxoptica, ophthalmologist of the highest category, LARISA BORYSIVNA KHARCHENKO (Kyiv, Ukraine).

ARTICLES FROM CATEGORY
Cetirizine is an effective and safe antihistamine (literature review, results of clinical researches)
All-Ukrainian Scientific and Practical Conference “Aspects of Internal Medicine in Wartime 2024"
Increased Anxiety Syndrome as a Factor of Child Behavioral and Health Disorders during Martial Law

CARD-NOTIFICATION OF AN ADVERSE DRUG REACTION AND/OR LACK OF EFFICACY OF THE MEDICINE

INFORMATION ABOUT THE PATIENT

SUSPECTED AR/LE

Suspected AR (describe each clinical manifestation of the AR with dates and times of onset and end and outcome)/Indication of the LE

INFORMATION ABOUT SUSPECTED MEDICINES

INFORMATION ABOUT RELATED MEDICINES

(with the exception of drugs used to correct the effects of AR/LE)
(concomitant diagnoses, laboratory and instrumental studies, allergy history, pregnancy with gestational age, method of conception, pregnancy outcome (if the pregnancy ended, the date of delivery, type of delivery, etc.)

Information about the messenger

INFORMATION ABOUT THE MEDICAL/PHARMACY SPECIALIST

(if not the notifier)

MESSAGE CARD for the patient

to provide the patient and/or his/her representative with information on adverse drug reactions and/or lack of efficacy of the drug

INFORMATION ABOUT THE PATIENT

Information about the suspected medicine

Information on the prescription of the suspected medicinal product

Information about the messenger

Information about the physician, healthcare facility and place of residence of the patient who had an adverse medicine reaction and/or lack of efficacy of the medicine

розробка сайту Estetic web design